Miranda Schmalfuhs

Resonating with Younger Demographics While Maintaining Medical Accuracy & Sensitivity

Amy Hessels, Bayer‘s vice president of marketing, talks about how to engage younger demographics and how the Your Decision campaign contributes to broader conversations about women's reproductive autonomy and healthcare access.

Republicans are aiming for major reductions in federal spending, and Medicaid seems a likely target. But the politics of Medicaid are tricky as the program has expanded and covered more people.

Drug Tariffs Will Harm Patients, AstraZeneca Chairman Says

Tariffs on pharmaceuticals would hurt patients and drugs should be exempt from these levies, AstraZeneca Plc’ Chairman Michel Demaré said.

Personalized Medicine Market Forecast Report and Company Analysis 2025-2033

The "Personalized Medicine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The market is expected to reach US $1 trillion by 2033 from US $546.97 billion in 2024, with a CAGR of 7.05% from 2025 to 2033.

Shout out to Amanda Bellitti, LSW and Dolores Garcia-Hoffman for an excellent and thought-provoking presentation on a topic that doesn't get as much attention as it should!

Have news you want us to share in Pharma Pulse? Reach out to Editor 

Articles

Pharma Pulse 4/14/25:  How Deep Will Medicaid Cuts Go? Resonating with Younger Demographics & more

Long-Term Sustainability for Diverse Trial Initiatives

LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses how Takeda will ensure that diversity and inclusion remain a priority in its clinical trials moving forward.

Payers Consider Policy Options for Access to GLP-1 Obesity Medications

A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability issue of obesity medications such as Wegovy and Zepbound.

Novartis Pledges $23 Billion US Investment as Tariffs Loom

Swiss pharmaceutical giant Novartis AG said it would invest $23 billion in the US over the next five years to ensure all its key drugs for Americans are made in the country, news that comes as President Donald Trump has promised to impose tariffs on global drugmakers.

Survey Reveals: Americans Surprised by Prescription Costs but Rarely Discuss Financial Challenges With Pharmacists

New research from Lumicera Health Services, the specialty pharmacy subsidiary of Navitus Health Solutions, reveals a dual challenge in healthcare today: many Americans are feeling the strain of prescription costs, yet most aren't taking full advantage of the pharmacists they trust. A survey of 2,000 Americans aged 18+ found that 75% have been surprised by the cost of a medication – but few are initiating conversations that could lead to solutions. 74% of respondents have never discussed financial challenges with their doctor or pharmacist.

Thanks Pharamceutical Commerce! This executive order should help patients understand what the are going to pay for drugs before they get them.

The latest news for pharma industry insiders.

Pharma Pulse 4/11/25: Long-Term Sustainability for Diverse Trial Initiatives, Payers Consider Policy Options for GLP-1 Access & more

Treating Chronic Cough with Digital Therapeutics

 about this new technology, along with how digital therapeutics have the ability to change the ways that patient symptoms are captured and measured by HCPs. She also discussed how new technologies like AI are expanding opportunities to implement digital therapeutics across the industry.

Study Finds ADHD Stimulants Have Minimal Effect on Cardiovascular System

Small changes in blood pressure and pulse were shown in patients of all ages, and the authors suggested that these are monitored carefully in patients being treated for ADHD.

Global Pharma Stocks Slide on Tariff Threat

Shares in large US and European drugmakers slide, underperforming amid a broad market slump, after President Donald Trump said the US was planning to announce “a major tariff on pharmaceuticals” soon. BMO Capital Markets Biotech and Pharma Analyst Evan Seigerman has more on the story. (Source: Bloomberg)

GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025

GSK plc has announced the recipients of its COiMMUNITY Initiative grant program, awarding nearly $2 million to 15 regional, state and national non-profits and community-based groups working to boost adult immunization through improved vaccine education, outreach and access.

Looking forward to hearing more on how innovation can drive efficiency and excellence in operations at LogiPharma!

Pharma Pulse 4/10/25: Treating Chronic Cough with Digital Therapeutics, ADHD Stimulants Have Minimal Effect on Cardiovascular System & more

Effectively Cutting Through the Misinformation Noise: Bayer’s Your Decision Campaign

Amy Hessels, vice president of marketing, Bayer, discusses how its Your Decision campaign tackles misinformation about reproductive health by providing the information to empower women to discuss options with healthcare providers.

Addressing Drug Shortages: A Call to Action for Pharmacists and Policymakers

Managing the challenge requires a multifaceted approach with all stakeholders.

European Pharma Companies Warn of Exodus to US as Tariffs Loom

Pharmaceutical companies warned European Commission President Ursula von der Leyen of a potential exodus to the US as tariffs loom, an industry group said following a meeting Tuesday.

Weight Loss Drugs Market Global Research 2025-2035

The "Weight Loss Drugs Market - A Global and Regional Analysis: Focus on Type, Mechanism of Action, Route of Administration, Distribution Channel, and Country-Level Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

The weight loss drugs market has experienced significant growth in recent years, largely driven by the increasing global prevalence of obesity and related health conditions. As more individuals seek effective and convenient solutions for managing their weight, the pharmaceutical industry has responded by offering a variety of drug options designed to aid in weight loss or help maintain a healthy weight.

“To move at speed, you need to partner with people that are better than you.” This was just one of several memorable quotes fromRuth Beadle of Sanofi’s LogiPharma presentation on “chasing the miracles of science to improve people’s lives.” More info on the session to come viaPharmaceutical Commerce.